|
Download PDF Is the second jab of an anti-SARS-CoV-2 vaccine reasonable after guillain–Barre syndrome following the first dose?  
This is a temporary file and hence do not link it from a website, instead link the URL of this page if you wish to link the PDF file.
To read this article you will require Adobe© Acrobat Reader, if you do not have this installed you can download it from here
Support open access
Recommend
 |
Subscribe
  |
|
